Lmr Partners LLP Astrazeneca PLC Transaction History

Lmr Partners LLP

$18.1 Billion
Q3 2025

A detailed history of Lmr Partners LLP transactions in Astrazeneca PLC stock. As of the latest transaction made, Lmr Partners LLP holds 25,700 shares of AZN stock, worth $2.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

25,700

Previous 22,895 12.25%

Holding current value

$2.3 Million

Previous $1.6 Million 23.26%

% of portfolio

0.01%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$68.72 - $82.11 $90.3 Million - $108 Million	1,314,003 Added 5739.26%	1,336,898 $103 Million
Q2 2025 Aug 14, 2025	BUY	$64.87 - $75.0 $1.46 Million - $1.69 Million	22,545 Added 6441.43%	22,895 $1.6 Million
Q1 2025 May 15, 2025	SELL	$65.37 - $77.96 $9.26 Million - $11 Million	-141,612 Reduced 99.75%	350 $25,000
Q4 2024 Feb 14, 2025	BUY	$63.2 - $79.58 $8.01 Million - $10.1 Million	126,676 Added 828.71%	141,962 $9.3 Million
Q3 2024 Nov 07, 2024	SELL	$76.67 - $87.62 $812,702 - $928,772	-10,600 Reduced 40.95%	15,286 $1.19 Million

Q2 2024 Aug 14, 2024	SELL	$66.81 - $80.83 $16.3 Million - $19.7 Million	-243,230 Reduced 90.38%	25,886 $2.02 Million
Q1 2024 May 15, 2024	SELL	$61.03 - $69.57 $512,652 - $584,388	-8,400 Reduced 3.03%	269,116 $18.2 Million
Q4 2023 Feb 14, 2024	SELL	$61.89 - $69.28 $7.71 Million - $8.63 Million	-124,600 Reduced 30.99%	277,516 $18.7 Million
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $37.3 Million - $41.3 Million	-575,319 Reduced 58.86%	402,116 $27.2 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $25.3 Million - $27.5 Million	362,607 Added 58.98%	977,435 $70 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $38.8 Million - $44 Million	614,828 New	614,828 $42.7 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $14.6 Million - $17.3 Million	-271,173 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $15.1 Million - $16.5 Million	271,173 New	271,173 $16.4 Million
Q1 2021 May 17, 2021	SELL	$47.16 - $54.44 $5.97 Million - $6.89 Million	-126,605 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$48.52 - $58.02 $933,961 - $1.12 Million	-19,249 Reduced 13.2%	126,605 $6.33 Million
Q3 2020 Nov 16, 2020	BUY	$53.07 - $61.1 $5.62 Million - $6.47 Million	105,854 Added 264.64%	145,854 $7.99 Million
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $1.72 Million - $2.21 Million	40,000 New	40,000 $2.12 Million

Others Institutions Holding AZN

# of Institutions

1,498

Shares Held

500M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Account